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Abstract
Background: Axonal injury of the optic nerve (ON) is involved in various ocular diseases, such as glaucoma and
traumatic optic neuropathy, which leads to apoptotic death of retinal ganglion cells (RGCs) and loss of vision.
Caspases have been implicated in RGC pathogenesis. However, the role of caspase-7, a functionally unique caspase,
in ON injury and RGC apoptosis has not been reported previously. The purpose of this study is to evaluate the role
of caspase-7 in ON injury-induced RGC apoptosis.
Results: C57BL/6 (wildtype, WT) and caspase-7 knockout (Casp7−/−) mice were used. We show that ON crush
activated caspase-7 and calpain-1, an upstream activator of caspase-7, in mouse RGCs, as well as hydrolysis of
kinectin and co-chaperone P23, specific substrates of caspase-7. ON crush caused a progressive loss of RGCs to
28 days after injury. Knockout of caspase-7 partially and significantly protected against the ON injury-induced RGC
loss; RGC density at 28 days post ON crush in Casp7−/− mice was approximately twice of that in WT ON injured
retinas. Consistent with changes in RGC counts, spectral-domain optical coherence tomography analysis revealed
that ON crush significantly reduced the in vivo thickness of the ganglion cell complex layer (including ganglion cell
layer, nerve fiber layer, and inner plexiform layer) in the retina. The ON crush-induced thinning of retinal layer was
significantly ameliorated in Casp7−/− mice when compared to WT mice. Moreover, electroretinography analysis
demonstrated a decline in the positive component of scotopic threshold response amplitude in ON crushed
eyes of the WT mice, whereas this RGC functional response was significantly higher in Casp7−/− mice at 28 days
post injury.
Conclusion: Altogether, our findings indicate that caspase-7 plays a critical role in ON injury-induced RGC death,
and inhibition of caspase-7 activity may be a novel therapeutic strategy for glaucoma and other neurodegenerative
diseases of the retina.
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Background
Axonal injuries occur in a wide range of CNS disorders.
They contribute to neuronal damage in diseases and
trauma of the human brain and spinal cord. Similarly,
injury to the optic nerve (ON), an extension of the CNS,
is associated with various ocular diseases and abnormal-
ities, such as glaucoma, traumatic optic neuropathy, ische-
mic optic neuropathy, and compressive optic neuropathy.
In humans, there are approximately 1.2 million axons in
the ON. They originate from retinal ganglion cells (RGCs)
in the inner retina and are responsible in transmitting
image-forming visual and other signals from the retina to
the visual centers and circadian pacemakers in the brain
[1]. Damage to these axons leads to RGC apoptotic death,
and consequently, loss of vision and disturbance of the
circadian rhythm [2].
Apoptosis of RGC involves caspases. Caspases are a
family of cysteine proteases that activate apoptotic path-
ways. They serve as either ‘initiators’ or ‘effectors’ based
on their molecular functions. The initiator caspases,
such as caspases-2, −8, −9, and −10, cleave and activate
effector caspases, such as, caspases-3, −6, and −7, which,
in turn, hydrolyze target proteins and initiate apoptosis [3].
The involvement of specific caspases in optic neuropathy,
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glaucoma, and RGC death has been previously implicated.
For example, in the ON of glaucoma patients, more axons
were found to express caspase-3 [4]. Similarly, activation of
specific caspases occurs in retinas of animal models of ON
injury, glaucoma, and RGC degeneration: (a) ON crush
activates caspase-2 [5]; (b) ON axotomy activates
caspases-3, −6, −8, and −9 in RGCs [6–11]; (c) higher
levels of active caspases-3, −8, and −9 were shown in
the rat retina subjected to chronic ocular hyperten-
sion [12–17]; (d) retinal ischemia/reperfusion activates
both caspases-2 and −3 [18, 19] with a reported reduction
in caspase-7 expression [19]; and (e) intravitreal injection
of kainate cleaved caspase-3 with an increase in effector
caspase activity [20]. Interestingly, other than caspase-2
[5, 21], inhibition or down-regulation of other initiator
caspases or caspase-3 only provides partial protection
against injury-induced RGC death [7–9, 12, 16].
Despite the studies described above, very little is
known about the involvement of a unique caspase,
caspase-7, in RGC apoptosis. Until recently, contribution
of caspase-7 to neuronal apoptosis was controversial.
Previously, it was generally believed that caspase-7 was
not present in the CNS, not activated if present, or even
if activated, ineffective in inducing apoptosis [22]. Further-
more, because caspase-7 exhibits a high degree of hom-
ology with caspase-3, it was speculated that caspase-7
simply served as a redundant version of caspase-3, and
thus did not play a critical role in the apoptosis cascade
[22]. However, it was later determined that caspase-7
cleaves exclusive substrates different from those of
caspase-3, such as kinectin and co-chaperone P23 [23–
25]. Several other non-ocular studies strongly suggest that
caspase-7 has a critical, non-redundant role in apoptotic
cell death and in normal development [26, 27]. For
example, Larner et al. demonstrated that caspase-7 is
upregulated and activated in the rat brain after trau-
matic brain injury [28]. Unlike other caspases, only
caspase-7 can be activated by calpain-1 [29], indicating
that caspase-7 may be a unique concomitant sensor of
Ca2+ dysregulation, via changes in calpain-1 activity, and
the classical caspase activation, two important death cas-
cades in RGCs.
Thus, the objective of this study is to evaluate the in-
volvement of caspase-7 in ON injury-induced RGC
apoptosis in mice. In this study, injury to the ON was
produced by intraorbital ON crush, which initiates rapid
onset and progression of RGC apoptotic death [30, 31].
We showed that caspase-7, together with its upstream
activator calpain-1, were activated and that the select-
ive caspase-7 downstream substrates, P23 and kinec-
tin, were hydrolyzed. We further showed that knockout of
caspase-7 significantly both morphologically and func-
tionally protected from the ON crush-induced loss of
RGCs.
Results
Caspase-7 activation by ON injury
In control, uninjured mouse retinas, the level of activated
(cleaved) caspase-7 was typically below the detection limit.
Injury to the ON activated retinal caspase-7 in a time-
dependent manner. Activated caspase-7 was not detected
in western blots of retinal protein extracts of wild type
(WT) mice at pre-injury, as well as 3 h and 6 h after ON
crush. Active caspase-7 significantly (p < 0.01) increased at
12 h in ON crushed eyes compared to the uninjured
control eyes. Levels continued to increase at 1 d and
3 d (p < 0.001), and appeared to plateau between 3 d
and 7 d (Fig. 1), indicating that ON crush activated
caspase-7 in the retina. It is interesting to note that
while it takes 3 d [6] or later [32] for caspase-3 to be
activated by ON injury, significant activation of caspase-7
in our study was observed at as early as 12 h after injury.
The cellular localization of the activated caspase-7 in
the retina was further evaluated by immunohistochemis-
try. Consistent with the Western blot analysis, there was
no immunoreactivity of cleaved caspase-7 in the retina
Fig. 1 Activation of caspase-7 in mouse retina by ON crush. a
Representative western blot images of pro- (uncleaved) and activated
(cleaved) caspase-7 in protein extracts from ON crush (12 h, 1 d, 3 d,
and 7 d post-injury) and control uninjured retinas of WT mice. b
Densitometry analysis of western blot images showing a significant
increase of active caspase-7 levels in ON crush eyes at the indicated
time points when compared to uninjured eyes (Right graph).
The values were normalized to β-actin and presented as the
mean ± SD (n = 4). **: p < 0.01, ***: p < 0.001 by unpaired, two-tailed
Student’s t-test
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of uninjured eyes (Fig. 2). At 3 d after ON crush, there
was an obvious increase in the level of cleaved caspase-
7, which located mainly in the cytoplasm of cells in the
ganglion cell layer (GCL) and co-localized with the spe-
cific RGC marker, RNA binding protein with multiple
splicing (RBPMS) (Fig. 2), indicating that ON crush acti-
vates caspase-7 primarily in RGCs.
Association of caspase-7 activation with calpain-1 activation
Calpain activation is associated with neuronal degener-
ation and cell death in a number of tissues, including
the retina. In retinal abnormalities, the calpain pathway
is involved in ischemia [33], excitotoxicity [34], experi-
mental glaucoma [35], and photoreceptor degeneration
[36, 37]. Caspase-7, unlike other caspases, is uniquely ac-
tivated by calpain-1 [29]. Thus, we evaluated whether
calpain-1 was involved in ON crush-induced RGC death.
Western blot analysis demonstrated that calpain-1 was
significantly activated in the retina at early time points
of 12 h (p < 0.05) and 1 d (p < 0.01) after ON crush (Fig. 3).
However, the level of activated calpain-1 returned to the
basal level prior to 3 d. These findings are consistent with
the notion that axonal damage induced a transient
activation of calpain-1 that may trigger caspase-7 acti-
vation, which in turn contributes to the pro-apoptotic
cascade in RGCs.
Cleavage of caspase-7-selective substrates by ON injury
Effector caspases-3 and −7 facilitate apoptosis by hydro-
lyzing and activating downstream substrates. Some sub-
strates, such as poly (ADP-ribose) polymerase (PARP),
are common to both caspases. Other substrates, such as
kinectin and co-chaperone P23, are cleaved selectively
and more efficiently by caspase-7 compared to caspase-3
[23, 25, 24]. Therefore, we tested whether these caspase-
7-selective substrates were cleaved in ON crush-induced
retinal injury. To evaluate this, we compared protein ex-
tracts of whole retinas from ON crushed (7 d post
injury) and uninjured eyes of WT and Casp7−/− mice.
We found minimal or undetectable hydrolysis of PARP,
kinectin, or P23 in the uninjured retinas of either WT or
Casp7−/− mice (Fig. 4). Crush of the ON significantly
(p < 0.05) increased hydrolysis of the non-selective
substrate PARP in both mouse strains, while hydrolysis of
caspase-7-selective substrates, kinectin and P23, was only
observed in the WT but not the Casp7−/− animals (Fig. 4).
Fig. 2 Activation of caspase-7 in RGCs by ON crush. Representative images of retinal cryosections from an uninjured control eye of WT mouse
(upper panel) and an eye 3 d after ON crush (lower panel), immunolabeled with cleaved caspase-7 antibody (green fluorescence), RBPMS antibody
(red), and DAPI (blue). ON crush increased cleaved caspase-7 levels mainly in the ganglion cell layer, most of which co-localized with the RGC-specific
marker RBPMS (arrows). Scale bars = 50 μm. GCL: ganglion cell layer, IPL: Inner plexiform layer, INL: inner nuclear layer
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Collectively, these results indicate that ON crush activates
caspase-7.
Protection of Casp7 knockout against ON crush-induced
RGC loss
To assess if caspase-7 activation plays a critical role in
ON injury-induced RGC apoptosis, we evaluated the
effects of ON crush in Casp7−/− mice compared to WT
animals. The Casp7−/− mouse has been characterized
previously [38], and the knockout of caspase-7 protein
expression was confirmed in this study (Additional file
1: Figure S1). As shown in retinal cross-sections (Fig. 5a),
the densities of RBPMS-positive cells in the GCL of WT
and Casp7−/− mice were similar prior to ON crush. In
the WT retinas, the RGC number declined both at 7 d
and 28 d after ON crush, while there appeared less loss
in the Casp7−/− retina. To quantify this observation, RGCs
were counted in RBPMS-labeled retinal flat mounts from
each study group. Two 40x images were taken from per-
ipheral and mid-peripheral regions of each of the four
quadrants of each retina. Representative flat mount im-
ages from mid-peripheral regions are shown in Fig. 5b.
The RGC numbers of the eight images from each retina
were counted and averaged. Figure 5c demonstrates that
RGC densities in uninjured eyes of WT and Casp7−/− ani-
mals were similar and stable over the study period. ON
crush caused a time-dependent loss of RGCs in WT mice.
The loss was statistically significant (p < 0.05) at 7 d after
injury, and continued to deteriorate at 14 d and 28 d. At
28 d, the remaining number of RGCs in the ON crush
eyes was 38 ± 4 % (n = 6 retinas) that of the uninjured
eyes. In contrast, although the number of RGCs in ON
crush eyes of Casp7−/− mice also significantly (p < 0.05)
decreased starting from 7 d, the extent of RGC loss was
significantly (p < 0.05) less in the Casp7−/− mice compared
to WT mice. Interestingly, the number of RGCs of these
animals appeared to stabilize from 7 d to 28 d after ON
injury and was statistically different from WT retinas
at these time points. At 28 d, 76 ± 3 % of the RGCs
remained, which was significantly (p < 0.05) higher than
that of WT eyes. This finding indicates that knockout of
caspase-7 partially protects the RGC loss induced by ON
crush, and suggests that caspase-7 plays an important role
in this pathophysiological change.
Protection of Casp7 knockout against ON crush-induced
thinning of the retina
In addition to the evaluation of post-mortem retinal tis-
sues, we also used the spectral domain-optical coherence
tomography (SD-OCT) to assess in vivo retinal layer
thickness of WT and Casp7−/− mice with or without ON
crush. Our previous study showed that ON crush causes
thinning of the retina, primarily due to thinning of the
ganglion cell complex (GCC; comprising the nerve fiber
layer (NFL), GCL, and inner plexiform layer (IPL)) [31].
In the current study, the GCC thicknesses at peripheral
and central regions of the retina in uninjured eyes of
WT and Casp7−/− animals were equivalent and did not
change over the 28 d study period (Fig. 6). Similar to
our previous findings, thinning of GCC occurred at 7 d
(p < 0.05) after injury in the ON crush eyes of WT mice.
At 28 d, the thickness of GCC was only 68 ± 6 % and
70 ± 4 % of the uninjured eyes in peripheral and cen-
tral retina, respectively. Most importantly, the ON
crush-induced thinning of GCC was partially but sig-
nificantly (p < 0.05) ameliorated in the Casp7−/− mice
(Fig. 6). At 28 d after injury, GCC thickness was 84 ± 4 %
and 87 ± 5 % of that of uninjured eyes in peripheral and
central retina respectively. These results provide temporal
in vivo morphological evidence corroborating the protect-
ive effects of Casp7 knockout against ON crush-induced
RGC loss.
Protection of Casp7 knockout against ON crush-induced
loss of RGC function
In addition to morphological assessments, we also eva-
luated the potential protection of caspase-7 knockout
against ON crush-induced loss of RGC function. The
positive STR (pSTR) amplitude in the ERG has been
shown to be a useful measurement of RGC function
Fig. 3 Activation of calpain-1 in mouse retina by ON crush. a
Representative western blot images of calpain-1 in protein extracts
after ON crush (12 h, 1 d, 3 d, and 7 d post-injury) and control
uninjured retinas of WT mice. b Densitometry analysis of western
blot images showing a significant increase of calpain-1 expression at
12 h and 1 d in ON crush eyes compared to uninjured eyes. The values
were normalized to β-actin and presented as the mean ± SD (n = 4).
*: p < 0.05, **: p < 0.01 by unpaired, two-tailed Student’s t-test
Choudhury et al. Molecular Neurodegeneration  (2015) 10:40 Page 4 of 14
Fig. 4 Cleavage of caspase-7 selective substrates by ON crush. a Representative western blot images of uncleaved and cleaved PARP, kinectin, as well
as cleaved and uncleaved co-chaperone P23 in retinal protein extracts from WT or Casp7−/− mice, uninjured or 7 d after ON crush. b-d Densitometry
analysis of the corresponding western blot images showing that ON crush induced hydrolysis of kinectin and P23 only in the WT mouse. The values
were normalized to β-actin and presented as the mean ± SD (n = 4). *: p < 0.05 by One Way-ANOVA then Tukey–Kramer post hoc test
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Fig. 5 (See legend on next page.)
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Fig. 5 Protection by caspase-7 knockout against ON crush-induced RGC loss. a Representative retina cross-section images with RBPMS immunolabeling
of WT and Casp7−/− mice. Images of both ON crush (7 d and 28 d post injury) and uninjured control eyes are shown. GCL: ganglion cell layer, INL: inner
nuclear layer, ONL: outer nuclear layer. Scale bar = 100 μm. b Representative images showing RBPMS immunolabeled retinal flat-mounts of WT and
Casp7−/− mice. Images of both ON crush (7 d, 14 d, and 28 d post injury) and uninjured control eyes are shown. Scale bar = 100 μm. c Quantitation of
RBPMS-positive RGCs in uninjured and ON crush flat-mounted retinas of WT and Casp7−/− mice. There was no difference in RGC densities between
uninjured eyes of WT and Casp7−/− mice. ON crush caused a steady decline in the number of RGCs in WT retina in comparison to Casp7−/− retina,
which showed a significant preservation of RGCs. The values were represented as mean ± SD (n = 6). *: p < 0.05 versus the respective uninjured control
group, #: p < 0.05 versus the “WT (ON crush)” group by One Way-ANOVA then Tukey–Kramer post hoc test
Fig. 6 Protection by caspase-7 knockout against ON crush-induced thinning of retinal layers. a Representative SD-OCT images showing in vivo
thickness of retinas of WT and Casp7−/− mice. Images of both ON crush (7 d and 28 d post injury) and uninjured control eyes are shown.
GCC = combined thickness of NFL, GCL, and IPL. b Graphic representation of fundus of mouse eye showing approximate locations of retina
thickness measurements. c Cross sectional images of mouse retina. Eight horizontal volume scans of retina at 100, 200, 300 and 400 μm through
the area dorso-temporal from the ON (superior retina, 4 scans) and the area ventro-temporal from the ON (inferior retina, 4 scans) were used
to evaluate GCC layer thickness. For measuring the GCC thickness at the peripheral retina, two calibrated calipers were placed at 400 μm and
500 μm on both sides of the center of each scan/optical slice. The peripheral thickness of the GCC was determined by averaging the 32
measurements. Similarly, to measure the GCC thickness of the central region of the retina, two calibrated calipers were placed at 100 μm and
200 μm at both sides of the center of each optical slice at 200 and 300 μm superior or inferior of the ON head. The central thickness of the GCC
was determined by averaging the 16 measurements. Quantitation of GCC thickness in both the peripheral (d) and central (e) retinas of WT and
Casp7−/− uninjured and ON injured eyes. The values were represented as mean ± SD (n = 6). *: p < 0.05 versus the respective uninjured control
group, #: p < 0.05 versus the “WT (ON crush)” group by One-Way ANOVA then Tukey–Kramer post hoc test
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[31]. The pSTR amplitudes of uninjured eyes were simi-
lar between WT and Casp7−/− mice (Fig. 7). ON crush
induced a time-dependent, progressive, and significant
(p < 0.05) decline in the RGC function in WT mice
starting 7 d after injury. At 28 d, the pSTR was only
39 ± 8 % of that of uninjured eyes. RGC function was
significantly (p < 0.05) protected by approximately half
in the Casp7−/− mice (Fig. 7). These results demonstrated
that knockout of Casp7 partially protected against the ON
crush-induced RGC morphological and functional loss.
Discussion
In many neurodegenerative diseases including glaucoma,
axonal injury is a critical insult leading to apoptotic
death of RGCs [39–41]. Although previous research has
highlighted a central role of caspases as mediators of
RGC apoptosis, the specific role of the distinct effector
caspase, caspase-7, was not clear. We used ON crush as
an experimental model of CNS injury to delineate this
relationship. Similar to previous findings [31, 42, 43], we
observed a ∼ 60 % decrease in RGC density at 28 d post
injury in adult mice.
We found that caspase-7 was activated in RGCs follow-
ing ON crush starting at 12 h post injury, and activation
reached a plateau at 3 d. Consistent with this finding, we
also showed the activation of calpain-1, an upstream
activator of caspase-7, in the ON crush-injured retina.
Since the enzymatic site of caspase-7 differs from that of
caspase-3, substrates hydrolyzed by caspase-7 differ from
those of caspase-3. In our study, we observed the hydroly-
sis of the caspase-7-selective substrates kinectin and co-
chaperone P23. Together, our results demonstrate that
ON crush activates caspase-7 in the mouse retina.
The finding that caspase-7 was activated in a majority
of RGCs as early as 12 h after injury is intriguing. In
comparison, activation of caspase-3 begins at 3 d [6] or
later [32] after ON injury and is typically only observed
in only a fraction of RGCs, likely those actively going
through apoptosis. Since RGC death starts at or after 3
d post ON crush and not all RGCs immediately become
apoptotic [31], our findings suggest that caspase-7 acti-
vation is involved in an earlier step in the apoptotic sig-
naling cascade. Compared to other caspases, caspase-7 is
unusual in that it can be activated by both the traditional
initiator caspase pathway as well as a novel calpain-1
pathway. It is interesting to note that activation of cal-
pain in our study was observed only at 12 and 24 h after
ON crush injury, whereas, activation of caspase-7 was
seen up to 7 days post injury. Together these data suggest
that caspase-7 activation may be initiated by the calcium-
calpain pathway and sustained by the traditional caspase
activation cascade. The functional implication of this
unique temporal profile and the exact role that caspase-7
plays require further investigation.
Although the exact role that caspase-7 activation in
ON damage plays remains unclear, biological functions
of substrates selectively hydrolyzed by caspase-7 may pro-
vide some clues. Co-chaperone P23, which was hydrolyzed
in the injured retina of only WT but not Casp7−/− mice, is
a ubiquitous protein found in most eukaryote tissues. It
binds and stabilizes Heat-shock protein 90 kDa (Hsp90),
serves as an essential component of the Hsp90 molecular
chaperone complex [44], and interacts with a variety of
Hsp90 clients, including most steroid receptors, active tel-
omerase, tyrosine kinases, and transcription factors [45].
In addition, genomic and proteomic studies further re-
vealed an extensive P23 molecular network independent
of Hsp90 clients [46]. Most intriguingly, this protein is
recognized as a pro-survival factor in cancer cells [25] and
perinatal mice [47]. Thus, caspase-7 mediated hydrolysis
of P23 will disrupt these intricate biological interactions
and may synergize with the canonical caspase-mediated
cell death pathway. Kinectin, another caspase-7 selective
substrate, is found on the cytoplasmic face of endo-
plasmic reticulum (ER) membranes [48], as well as
the cargo-binding site of conventional kinesins. It has
been implicated in the formation, stabilization, shap-
ing, and cytoskeletal interactions of sheet-like cisterns
of the ER [49]. As a motor-binding protein, kinectin
is also associated with active intracellular organelle
movements powered by kinesin, thus controlling intracel-
lular cargo transport [50]. These vital functions of kinectin
are expected to be compromised by caspase-7 activation.
To investigate the importance of caspase-7 in ON
crush-induced RGC loss, we assessed the potential RGC
protective effects of Casp7 knockout. Our results showed
significant protection of RGCs in the ON crushed eyes of
Casp7−/− mice when compared to WT mice 7 to 28 d post
crush. We demonstrated this protection using both mor-
phological and functional evaluations. Morphologically,
we analyzed post mortem RGC density and measured in
vivo thickness of retinal layers. RGC counts of flat-
mounted retinas indicated that ON crush dramatically re-
duced the density of these neurons in WT mice, with only
38 % remaining at 28 d post injury. In contrast, 76 % of
the RGCs survived this insult in Casp7−/− mice. An inter-
esting observation is that RGC density of these animals
appeared to stabilize from 7 d to 28 d compared to the
continuous decline in the WT animals. This suggests that
the protective effect of Casp7 knockout is not a transient
delay of neuronal death, and instead it may provide a
long-term protection.
SD-OCT analysis allows non-invasive, in vivo monitor-
ing of morphological changes of the retina. We showed
that GCC thickness significantly decreased in WT mice
from 7 to 28 d post ON crush. GCC is comprised of three
retinal layers: the NFL, containing RGC axons; the GCL,
containing RGC soma; and the IPL, containing the RGC
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Fig. 7 Protection by caspase-7 knockout against ON crush-induced loss of RGC function. a Representative STR-ERG waveforms from WT (left panels)
and Casp7−/− (right panels) mice. Upper panels show the representative waveforms before ON crush and lower panels show the representative
waveforms 28 d post crush. Blue lines represent the ON crushed left eyes and black lines represent the uninjured, contralateral (right) eyes. b pSTR
amplitudes of ON crush and uninjured eyes of WT and Casp7−/− mice at indicated time points. ON crush significantly decreased RGC function in a
time-dependent fashion as shown as a decline in pSTR amplitudes, which was significantly ameliorated in the Casp7−/− animals. Data are shown as
mean ± SD (n = 6). *: p < 0.05 versus the respective uninjured control group, #: p < 0.05 versus the “WT (ON crush)” group by One-Way ANOVA then
Tukey–Kramer post hoc test
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dendrites. ON injury causes loss of RGCs and thinning of
the GCC [51–53]. In comparison, ON crush-induced
thinning of the GCC was significantly and stably ame-
liorated in Casp7−/− mice from 7 to 28 d after injury.
Together, the in vivo and post mortem results indicate
that absence of caspase-7 protects against morphological
deterioration of RGCs caused by ON injury.
Most importantly, knockout of Casp7 not only pre-
served RGC density and structures, but also significantly
protected against loss of RGC function subsequent to
ON crush. The STR response is derived mainly from
RGCs [54]. In WT mice, we found an approximately
35 % decrease in pSTR responses at 7 d and approxi-
mately 65 % at 28 d after ON crush. This coincides with
a time-dependent RGC loss in WT mice after ON crush.
In contrast, the pSTR response in Casp7−/− mice showed
only a 15 % reduction at 7 d and a 25 % decrease at 28 d
after ON crush, clearly showing protection of RGC
function.
Our discovery that caspase-7 plays a critical role in ON
crush-induced RGC loss is important for the following
reasons. Being a concomitant sensor of both the calpain
and traditional caspase pathways, caspase-7, through hy-
drolysis of its specific downstream substrates may regulate
unique and yet-to-be-revealed mechanisms in controlling
cell death. In addition, caspase-7 is a p53 responsive gene;
p53 binds to the first intron of the human and mouse
caspase-7 gene [55]. p53 is a transcription factor, involved
in the regulation of neuronal viability after injury [56, 57].
Activated p53 can modulate mitochondrial membrane
permeability and the release of mitochondrial proteins
during apoptosis. p53 is phosphorylated and its pro-
apoptotic targets PUMA and Fas/CD95 are upregulated in
ON axotomy-induced RGC death [58]. It is interesting to
speculate that caspase-7 may be involved in this apoptosis
signaling mechanism.
Based on morphological and functional criteria, we
showed that Casp7 knockout was protective against ON
crush-induced loss of RGCs. However, this protection
was not complete (i.e., it did not reach the uninjured
levels), suggesting that caspase-7 is not the sole mediator
of this ON crush pathology and that other cellular path-
ways may be involved. It is likely that caspase-3 also
contributes to this injury. This is consistent with the
findings that inhibition of caspase-2, an upstream initiator
caspase for both caspases-3 and −7, via pharmacological
inhibition or siRNA provided almost complete protection
of RGC against ON crush-induced death for at least
30 days [5, 21]. Furthermore, caspase-independent path-
ways may also be involved in neuronal cell death associ-
ated with ON injury, such as mitochondria-mediated
death. Mitochondria are essential in controlling cell death.
Exposure of RGCs to TNF-α or hypoxia leads to
mitochondrial alterations, including the release of
cytochrome c and apoptosis inducing factor, leading
to RGC death through caspase-independent events
[59]. After ON injury, amplification of TNF-α activates
JNK, which causes RGC death [60]. Fernandes et al. have
shown that JNK signaling is a major early pathway trigger-
ing RGC death after axonal injury [61]. Moreover, reactive
oxygen species are associated with mitochondrial dysfunc-
tion and may be involved in signaling RGC apoptosis after
axonal injury [62]. Therefore, it is clearly important to de-
lineate the relative roles each of these signaling pathways
plays and their interactions in ON crush-induced RGC
death and other forms of CNS injury.
Conclusions
In conclusion, our findings demonstrated the important
role of caspase-7 in RGC apoptosis induced by ON
crush. Our results also show that knockout of Casp7
partially protects against ON crush-induced RGC loss
and the thinning of inner retinal layer thickness. Most
importantly, we found that RGC function was protected
by Casp7 knockout. Thus, inhibition of caspase-7 activity
may be a novel therapeutic strategy for neurodegenerative
diseases of the retina and the ON. Further studies need to
be performed to unravel the full mechanisms of caspase-
7-dependent and independent apoptotic pathways in ON
injury induced RGC apoptosis.
Methods
Animals
Female C57BL/6 J mice, serving as the WT control, and
caspase-7 knockout (Casp7−/−) (B6.129S6-Casp7tm1Flv/J)
breeders were purchased from the Jackson Laboratory
(Bar Harbor, ME). The Casp7−/− mice were backcrossed
with the C57BL/6 J strain for at least 10 generations, mak-
ing the C57BL/6 J strain an appropriate WT control. All
mice were maintained in 12:12 light/dark cycle and sup-
plied with food and water ad libitum. All experiments
were conducted in accordance with the ARVO Statement
of the Use of Animals in Ophthalmic and Vision Research
and the University of North Texas Health Science Center’s
Institutional Animal Care and Use Committee guidelines.
Optic nerve crush
ON crush was performed on the left eyes of C57BL/6 J
and Casp7−/− mice at 8–10 weeks of age according to a
previously described procedure [31]. Briefly, mice were
anesthetized by intraperitoneal injection of ketamine and
xylazine, (100 and 10 mg/kg body weight, respectively).
The cornea was anesthetized with a topical drop of
0.5 % proparacaine HCl (Alcon Laboratories, Fort Worth,
TX). The ON of the left eye was exposed intraorbitally
through a small opening made among the surrounding
extraocular muscles. A pair of self-closing forceps was
used to crush the ON approximately 1 mm behind the
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globe for 4 s. Care was taken not to block the blood flow
to the retina through the central retinal artery. The eye
was covered with antibiotic ointment (polymyxin B
sulfate and bacitracin; Bausch & Lomb, Tampa, FL). All
animals undergoing surgery were given buprenorphine
(0.05 mg/kg, subcutaneously) immediately after surgery.
Western blot analysis
Retinal protein extracts were obtained from dissected
retinas by sonication in mammalian protein extraction
buffer (Thermo Scientific, Rockford, IL) containing pro-
tease inhibitor and phosphatase inhibitor cocktails
(Thermo Scientific). Protein concentrations were deter-
mined using the Bio-Rad Dc protein assay according to
the manufacturer’s instructions (Bio-Rad Laboratories,
Richmond, CA). A total of 60 μg protein from each sam-
ple was loaded and electrophoresed on 15 % denaturing
polyacrylamide gels and then electrophoretically trans-
ferred to polyvinylidene fluoride membranes. Blots were
incubated in 5 % milk in Tris Buffered Saline Tween
solution (TBST; 20 mM Tris, 0.5 M NaCl, and 0.05 %
Tween 20, pH 7.4) for 1 h to block nonspecific binding.
Membranes were incubated overnight at 4 °C with pri-
mary antibodies diluted in Super Block T20 (Thermo
Scientific). The primary antibodies used were caspase-7
(1:1000, Cell Signaling, Danvers, MA, Cat # 9492),
calpain-1 (1:1000, Cell Signaling, Cat # 2556), kinectin
(1:1000, Novus Biologicals, Littleton, CO, Cat # NBP1-
91592), P23 (1:1000, GeneTex, Irvine, CA, Cat #
GTX112655), PARP (1:1000, Cell Signaling, Cat # 9542),
and mouse-anti-β-actin (1:5000; clone C4, Millipore, Bil-
lerica, MA, Cat # MAB1501). The following day, mem-
branes were washed with TBST 3X for a total of 30 min
and were incubated for 1 h with corresponding second-
ary antibodies: goat-anti-rabbit-horseradish peroxidase
(1:10,000; Thermo Scientific, Cat # 32460) or goat-anti-
mouse-horseradish peroxidase conjugated antibodies
(1:10,000; Thermo Scientific, Cat # 32430) diluted in TBST.
Membranes were washed 3X with TBST for 10 min each at
room temperature. The proteins were then visualized in a
FluorChem 8900 imager (Alpha Innotech, San Leandro,
CA) using ECL detection reagent Super Signal West Femto
Maximum Sensitivity Substrate (Thermo Scientific). The
relative expression of proteins was determined by densi-
tometry analysis and then normalized to β-actin.
Immunohistochemistry
Eyes from WT and Casp7−/− mice were enucleated and
fixed overnight in freshly prepared 4 % paraformalde-
hyde (PFA) in phosphate-buffered saline (PBS). After-
wards, eyes were submerged sequentially in solutions of
10 %, 20 % and 30 % sucrose for at least 1 h each. Eyes
were embedded in cryostat compound (Tissue TEK
OCT, Sakura Finetek, Torrance, CA) and frozen at −80 °C.
Sections (10 μm thick) were cut using a cryostat (Leica
Microsystem, Buffalo Grove, IL) and transferred to glass
slides. Retinal cryosections were soaked in PBS for 10 min
and blocked in 2 % goat serum, 0.3 % Triton X-100 in PBS
for 1 h at room temperature. The sections were double
immunolabeled with mouse monoclonal caspase-7 anti-
body (1:50, Santacruz Biotechnology, Dallas, TX, Cat #
SC-28295) and rabbit polyclonal RBPMS antibody (1:200,
Genetex, Irvine, CA Cat # GTX118619) overnight at 4 °C,
washed three times with PBS and incubated for 1 h with
the respective secondary antibodies at room temperature.
Secondary antibodies used were AlexaFluor488 goat-anti-
rabbit (1:1000; Life Technologies, Grand Island, NY, Cat #
A11008) and tetramethylrhodamine goat-anti-mouse
IgG (1:1000; Life Technologies, cat # T2762). Sections
were mounted with Vectashield Mounting Medium
containing DAPI (Vector Laboratories, Burlingame,
CA). Images were acquired using a Carl Zeiss inverted
microscope Axiom vision series (Carl Zeiss Microscopy,
Thornwood NY).
Retinal flat mounts and cell counts
Following fixation in 4 % PFA, the anterior segment of
each eye was removed and the posterior eyecup was
processed for whole mount immunostaining to quanti-
tate RGCs. Retinas from fixed eyes were carefully dis-
sected, flat-mounted on glass slides, and blocked in
0.3 % Triton X-100 in PBS containing 2 % goat serum
for 2 h. Retinas were then incubated in rabbit polyclonal
RBPMS antibody (1:200, diluted in 0.3 % Triton X-100
in PBS) overnight at 4 °C. Following washes in PBS, the
retinas were incubated with AlexaFluor488 goat-anti-
rabbit (1:1000, diluted in PBST) for 24 h at 4 °C and
then mounted with Vectashield Mounting Medium con-
taining DAPI (Vector Laboratories). Eight 40x images
were taken from peripheral and mid-peripheral regions
of the four quadrants of each retina. The number of
labeled cells from each image was counted. For each indi-
vidual retina, the RGC count was obtained by averaging
the eight counts for each retina.
Spectral domain-optical coherence tomography
SD-OCT imaging was performed using the Bioptigen
Envisu™ Ophthalmic Imaging System (Bioptigen, Durham,
NC) to measure GCC thickness (combination of NFL,
GCL, and IPL layers). Mice were anesthetized using a
ketamine/xylazine cocktail (100/10 mg/kg), and their pu-
pils were dilated with a drop of 2.5 % phenylephrine
hydrochloride (Bausch & Lomb). To prevent corneal
desiccation during the procedure, topical Systane Ultra®
lubricant eye drop (Alcon) was applied frequently and bi-
laterally. The retina was scanned with the rectangular
scanning mode consisting of 100 B-scan tomograms, each
with 1000 A-scans, by using InVivoVue software (Bioptigen
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Inc. Durham, NC). Horizontal volume scans of retina at
100, 200, 300 and 400 μm through the area dorso-temporal
of the ON head (superior retina) and the area ventro-
temporal of the ON head (inferior retina) were used to
evaluate the thickness of the GCC. For measuring the GCC
thickness at peripheral retina, two calibrated calipers were
placed at 400 μm and 500 μm on both sides from the cen-
ter of each of the eight optical slices. The peripheral GCC
thickness of each retina was determined by averaging the
32 measurements. To determine GCC thickness at central
retina, two calibrated calipers were placed at 100 μm and
200 μm on both sides of the center of optical slices that
were 200 and 300 μm superior or inferior to the ON head.
The central thickness of the GCC of each retina was
determined by averaging the 16 measurements.
Scotopic threshold response electroretinography
The STR of ERG was performed with the Handheld Multi-
species-ElectroRetinoGraph unit (Ocuscience, Kansas City,
MO) to assess the functional analysis of RGCs [31]. Mice
were dark-adapted overnight prior to ERG recordings.
During the whole procedure, mice were anesthetized using
1.5 % isoflurane. The mouse pupils were dilated with a
drop of 2.5 % phenylephrine, and the cornea was anesthe-
tized with a drop of 0.5 % proparacaine. A ground elec-
trode was inserted subcutaneously in the tail and two
reference electrodes were inserted subcutaneously under-
neath both eyes. Recording electrodes were placed on the
cornea. To maintain moisture, a drop of 2.5 % methylcel-
lulose was added to the concave side of a contact lens,
which was placed on the electrodes. Light stimuli (0.03
mcd · s/m2) were generated in a Ganzfeld dome with light
emitting diodes. Responses from 10 flashes with 2 s inter-
vals were averaged. The positive component of the STR
amplitude was quantified and analyzed by using ERG-
VIEW software (Ocuscience).
Statistical analysis
Results between two groups were analyzed for differ-
ences using the unpaired Student’s t-test (GraphPad
Prism 6.0; GraphPad Software, La Jolla, CA). Results
among three or more groups were compared using one-
way ANOVA followed by Tukey–Kramer post hoc test.
Statistical significance was determined at p values < 0.05.
Additional file
Additional file 1: Figure S1. Reduction in caspase-7 expression in the
retina of Casp7−/− mice. Representative western blot images of pro-caspase-7
in protein extracts from retinas from WT and Casp7−/− mice. (TIFF 42 kb)
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